Jan 24,2014

Mississippi telehealth project may be a model for the nation

A remote care management pilot that makes use of mHealth tools and services has been launched in Mississippi. Officials hope it will make an impact in the state with the highest percentage of adult diabetics and cut into the $3 billion in diabetes-related health costs that the state incurs each year. The Diabetes Telehealth Network was unveiled this week by Gov. Phil Bryant. The public-private partnership, which includes the University of Mississippi Medical Center, North Sunflower Medical Center, GE Healthcare, Intel-GE Care Innovations and CSpire Wireless, is being billed as the first of its kind, targeting at-risk residents in underserves areas.

PRODUCT

#rpm

View Analyst & Ambassador Comments
Go to original news
Nov 12,2014

Joslin, Glooko add activity tracker data to their HypoMap diabetes management system

Diabetes management technology company Glooko, which made its name with a universal cord and app for connecting glucometers to smartphones, introduced a feature today which lets patients feed activity data into its population health management software , the Glooko-Joslin HypoMap system . Currently, the graph takes in data from Fitbit, Jawbone, Withings, and iHealth devices (among others) as well as free apps like Moves and Runkeeper.

PRODUCT

#rpm

View Analyst & Ambassador Comments
Go to original news
Jan 04,2022

Smart Meter Remote Patient Monitoring Powered By AT&T IoT Connectivity Helps Improve Outcomes…

AT&T is teaming up with Smart Meter to improve health outcomes for patients with chronic conditions like diabetes and high blood pressure.

COLLABORATION PARTNERSHIP

#product & service

#rpm

View Analyst & Ambassador Comments
Go to original news
Apr 12,2022

Rimidi Named to AVIA Connect’s Top 50 Companies in Remote Patient Monitoring Report

Rimidi, a leading clinical management platform designed to optimize clinical workflows, enhance patient experiences and achieve quality objectives, announced today that it was recognized as a Top 50 Company in remote monitoring by AVIA Connect, the leading digital health marketplace.

#rpm

View Analyst & Ambassador Comments
Go to original news
Apr 29,2022

CareSignal Partners with Texas Association of Community Health Centers (TACHC) to Improve Outcomes for Underserved Patient Populations

Participating centers now offer CareSignal’s Deviceless Remote Patient Monitoring® technology to patients to monitor diabetes, hypertension, congestive heart failure, COPD, and social determinants of health.

COLLABORATION PARTNERSHIP

#product & service

#rpm

View Analyst & Ambassador Comments
Go to original news
Aug 26,2022

Teladoc Health & Cloud DX Partner in Canada to Enhance Remote Monitoring Solutions for Patients Across the Country

Teladoc Health the global leader in whole-person virtual care, together with Cloud DX, a leading remote patient monitoring ("RPM") platform, are pleased to announce that they have entered into a strategic partnership to better serve the remote monitoring needs of patients across Canada.

#rpm

#virtual care

View Analyst & Ambassador Comments
Go to original news
Mar 02,2021

CentraState Healthcare System Partners With Noteworth to Deliver Telemedicine Services and Extend Care Management Capabilities

Noteworth, a first-of-its-kind virtual care delivery platform including diabates services, announced its partnership with CentraState Healthcare System to extend the continuity of care for patients in the community. CentraState recently implemented Noteworth to launch multiple programs to expand their care delivery, including telehealth and remote prevention and care management capabilities for diabetes and hypertension.

COLLABORATION PARTNERSHIP

#institution

#telehealth

#rpm

View Analyst & Ambassador Comments
Go to original news
Mar 16,2021

Israel's DreaMed, Yale team up on AI diabetes monitoring

Israeli medical software company DreaMed Diabetes said on Monday it was partnering with Yale New Haven Health System to use artificial intelligence (AI) in monitoring insulin and glucose levels in children with Type 1 diabetes. DreaMed’s dose-optimisation software will be tested on 100 diabetic children at Yale New Haven Children’s Hospital, said Jennifer Sherr, a pediatric endocrinologist there. The subjects will use the system at least every three weeks, “and then we’ll see them in clinical follow-up at three months, and again at six months” to assess whether their overall control had improved, she said, noting the follow-ups could be virtual. The software uses patient data to create recommendations for insulin dose changes, if required.

COLLABORATION PARTNERSHIP

#r&d

#rpm

View Analyst & Ambassador Comments
Go to original news
Jun 12,2021

Wellthy Therapeutics demonstrates real world outcomes to manage chronic conditions

Wellthy Therapeutics, a leading digital therapeutics (DTx) company operating in Europe and Asia, recently conducted a 16-week real-world study, to test the real-world effectiveness, efficacy and remote patient monitoring and management capabilities of its Wellthy CARE ™ DTx platform. The platform consists of a clinical and behavioural intelligence engine, delivering care through a mobile app, paramedical dashboards, HCP dashboards and enterprise analytics. In this study, a clinically validated Type 2 Diabetes Digital Therapy was delivered through the Wellthy CARE DTx platform, to evaluate glycemic control in Type 2 Diabetes Mellitus (T2DM) patients of South Asian origin. The findings were published in the Journal of Medical Internet Research (JMIR) as a full text publication.

PRODUCT

#mobile app

#dtx

#rpm

View Analyst & Ambassador Comments
Go to original news
Jun 06,2021

Atos and Huma Enter Into Five-Year Partnership to Improve Healthcare and Research With Innovative Remote Monitoring Technologies

Atos and Huma have announced a 5-year strategic global partnership to shift healthcare and clinical trials from hospital to home. The partnership will focus on Huma’s modular platform which can power digital ‘hospitals at home’ up to national scale, as well as support pharmaceutical and research industries to run complex global decentralized clinical trials. The platform is already used in the US and across Europe for illnesses ranging from atrial fibrillation to diabetes to Covid-19. Atos will use its experience in implementing and scaling complex transformation projects to accelerate adoption of Huma’s technology. This will include investment by Atos worth up to €20 million split across R&D and go-to-market resources, including dedicated consulting and sales personnel. The investment in R&D will fast-track the integration of the Huma platform with other leading clinical platforms, as well as develop a dedicated video module.

COLLABORATION PARTNERSHIP

#r&d

#rpm

View Analyst & Ambassador Comments
Go to original news
Subscribe to RPM